Skip to content
The Policy VaultThe Policy Vault

TrudhesaUnited Healthcare

moderate to severe migraine headaches with or without aura

Preferred products

  • sumatriptan
  • zolmitriptan

Initial criteria

  • Diagnosis of moderate to severe migraine headaches with or without aura
  • AND History of failure (after at least 3 migraine episodes and a minimum of a 30-day trial), contraindication, or intolerance to one of the following oral triptans (document duration of trial): almotriptan (Axert), eletriptan (Relpax), frovatriptan (Frova), naratriptan (Amerge), rizatriptan (Maxalt/Maxalt-MLT), sumatriptan (Imitrex), zolmitriptan (Zomig)
  • AND History of failure (after at least 3 migraine episodes and a minimum of a 30-day trial), contraindication, or intolerance to both of the following: sumatriptan nasal spray (generic Imitrex nasal spray) AND Zomig nasal spray (zolmitriptan)

Approval duration

12 months